| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Derek McAllan, Robin James Scott Cridland |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 3.60p |
| Change Today | 0.55p |
| % Change | 18.03 % |
| 52 Week High | 4.25 |
| 52 Week Low | 2.10 |
| Volume | 2,171,609 |
| Shares Issued | 533.35m |
| Market Cap | £19.20m |
| Beta | 0.77 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:28 | 61,551 @ 3.53p |
| 16:18 | 10,244 @ 3.70p |
| 16:15 | 28,000 @ 3.70p |
| 16:14 | 10,198 @ 3.66p |
| 16:00 | 50,000 @ 3.66p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research